Metastatic prostate cancer can follow very different Roads depending on whether it is still androgen-sensitive or has become castration-resistant, where it has spread, how quickly PSA is changing, whether PSMA-positive disease is present, and what germline or tumor alterations have been found. Ronnie’s RoadMap keeps these branches separate because the timing and sequence of hormone therapy, chemotherapy, PARP-directed treatment, radiopharmaceuticals, radiation, and clinical trials can matter.
START WITH OPTIONS
What would help you today?
Cancer brings more than treatment questions. Choose what matters most right now. You can always explore another Road.
RoadMap is about OPTIONS. Medical. Emotional. Financial. Practical. Access. Support. Sometimes the next Road is another treatment. Sometimes it is another expert, an appeal, a resource—or another person who understands.
YOUR DIAGNOSIS & HISTORY
What is the prostate cancer story so far?
Ronnie’s original prostate RoadMap starts with timing, Gleason/Grade Group, local treatment, and when metastatic disease appeared.
GENETICS, BIOMARKERS & IMAGING
What testing has been completed?
Ronnie separated germline testing, tumor testing, imaging, and PSA trends because each can open a different treatment Road.
WHERE THINGS ARE NOW
Where has the cancer spread?
Ronnie’s RoadMap maps the metastatic pattern because bone-only, nodal-only, visceral, oligometastatic, and symptomatic disease can lead to different specialist discussions.
Urgent: severe new back pain with leg weakness/numbness, trouble walking, or new bladder/bowel changes can signal spinal cord compression and needs immediate medical evaluation.
HORMONE-SENSITIVE OR CASTRATION-RESISTANT?
Which pathway are you on now?
This was one of Ronnie’s most important prostate branches. The same metastatic cancer can require a different sequence once it progresses despite castrate testosterone.
TREATMENT HISTORY & CURRENT OPTIONS
Which treatments have already been part of your Road?
UPDATED THROUGH SEPTEMBER 2026
Major 2026 update: On July 31, 2026, FDA approved Pluvicto with an androgen-receptor pathway inhibitor for adults with PSMA-positive metastatic androgen-pathway modulation-naïve or -sensitive prostate cancer selected by an approved PSMA PET test.
Other important recent changes: Pluvicto’s mCRPC indication expanded in 2025 to certain PSMA-positive patients after an AR pathway inhibitor who are appropriate to delay taxane chemotherapy. In December 2025, niraparib + abiraterone + prednisone gained an mCSPC indication for BRCA2-mutated disease, and rucaparib received regular approval for BRCA-mutated mCRPC after AR-directed therapy.
YOUR TEAM, SYMPTOMS & TRIAL DETAILS
Who is reviewing the full picture?
Optional details that can improve TrialMagic matching
BUILD MY PROSTATE CANCER TREATMENT TEAM
Who should actually be at the table?
A useful treatment team depends on where the prostate cancer is, whether it is hormone-sensitive or castration-resistant, what treatment decision is next, and whether bone, spine, liver, lung, or other sites need their own specialist. Answer a few focused questions and RoadMap will name the disciplines that may matter.
Your oncologist does not have to be your entire treatment team. This RoadMap is designed to identify the disciplines that may add a real treatment option, procedure, imaging interpretation, safety intervention, or second opinion for your pattern of prostate cancer.
GENETIC & BIOMARKER TESTING
What would you like help understanding?
You do not need to know the difference between genetic testing and biomarker testing before you start. RoadMap can help you sort out what has been done, what may still matter, and what the results could mean.
Two kinds of testing can both matter.Genetic (germline) testing looks for inherited changes that may matter to you and your family. Biomarker or tumor testing looks at characteristics of the cancer that may help guide treatment or clinical-trial discussions. You do not have to know which one you need before asking for help.
YOUR SUPPORT ROADMAP
What would make today a little easier?
You do not need to complete a medical questionnaire to ask for help.
FINANCIAL HELP
What is creating the most financial pressure?
Choose anything that is making cancer harder financially. We’ll use this to point you toward the right kind of help.
EMOTIONAL SUPPORT
What feels heaviest emotionally?
INSURANCE & ACCESS
What kind of access problem are you facing?
PATIENT-OWNED APPEAL ROADMAP
Show us exactly why they said no.
Start with the denial. RoadMap will help organize their words → their rules → the contradiction → your evidence → the right peer → precedent → urgency → your story. You stay at the center of the appeal; your medical team supplies the clinical evidence and peer-to-peer expertise.
Upload the denial letter so the appeal workflow can be built around the insurer’s exact language and cited policy.
What does your own plan say?
Who made this decision?
Does this need to move fast?
What evidence defeats this denial?
Build to the denial. The packet can be 20 pages or 200 pages. Include documentation because it proves a point in this case—not because every appeal needs the same attachments.
Show them who you are.
Optional. A reviewer needs the medical evidence, but in some settings it can matter that the person behind the case becomes visible.
Where should the appeal go?
PRACTICAL HELP
What do you need help with?
Choose the barrier. RoadMap will take you straight to resources that can help.
SYMPTOMS & SIDE EFFECTS
What is making daily life harder?
Help for My Family or Caregiver
Start with direction—not more questions.
Today: Choose one family point person for appointments, medications, important phone numbers and the running question list. Give everyone else a specific job: meals, rides, school pickup, pet care, errands, laundry, or simply staying with the patient.
At appointments: Have one person listen and one take notes. Leave knowing what changed, what happens next, what symptoms require a call, and who to contact after hours.
For an exhausted caregiver: Hand off one task today and protect regular time completely off duty. Sleep, medications and the caregiver’s own medical appointments matter.
Ask the cancer center for: oncology social work, caregiver support, child-life/family support, nutrition, palliative care, transportation and financial navigation as appropriate.
Say YES to Hope: Survivor Line and FRIENDS for Your Journey can connect patients and families with someone who understands metastatic cancer.
THE DIFFICULT CONVERSATIONS
What do you want clear information about?
These are different kinds of care and planning. Choose what you need. RoadMap will explain it and take you directly to help.
YOUR PERSONAL ROADMAP
Here are OPTIONS worth exploring.
This is an organizing guide—not a treatment recommendation. Your care team knows the medical details RoadMap cannot see.
What You Told Us
Where You Can Go Next
These resources are matched to what you selected. Programs, funding and eligibility can change, so check current availability.
Your YES Connections
What Looks Important Right Now
Information You May Still Need
People Who May Belong in the Conversation
Possibilities to Discuss
Questions Worth Asking
Find My Team
RoadMap can turn the disciplines above into a practical specialist-search plan now—and is structured so named physician and center matching can be added without changing the patient flow.
Important: RoadMap is educational and does not diagnose cancer, determine eligibility, or recommend a specific treatment. Options depend on pathology, scans, prior treatment, organ function, overall health, goals, and expert review. New or rapidly worsening symptoms may require urgent medical attention.
Email My RoadMap
Enter the address where you'd like your RoadMap sent.
Use SEND to prepare your personalized RoadMap for email.
